Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. - Wikidata - awgldk - TriplyDB

Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.

Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.

http://www.wikidata.org/entity/Q47150783

about

Application of viromics: a new approach to the understanding of viral infections in humans.220 mutation in the hemagglutinin of avian influenza A (H7N9) virus alters antigenicity during vaccine strain development.Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018.Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018.Poor immunogenicity, not vaccine strain egg adaptation, may explain the low H3N2 influenza vaccine effectiveness in 2012-13.Assessing the benefits of early pandemic influenza vaccine availability: a case study for Ontario, Canada.Mapping the Evolutionary Potential of RNA Viruses.New Kids on the Block: RNA-Based Influenza Virus Vaccines.Epidemiological Studies to Support the Development of Next Generation Influenza Vaccines.Low population serum microneutralization antibody titer against the predominating influenza A(H3N2) N121K virus during the severe influenza summer peak of Hong Kong in 2017.Factors associated with influenza vaccination failure and severe disease in a French region in 2015.Genomic surveillance of avian-origin influenza A viruses causing human disease.Structural analyses reveal the mechanism of inhibition of influenza virus NS1 by two antiviral compounds Acquisition of Innate Inhibitor Resistance and Mammalian Pathogenicity During Egg Adaptation by the H9N2 Avian Influenza Virus Design of peptide epitope from the neuraminidase protein of influenza A and influenza B towards short peptide vaccine development Clinical Advances in Viral-Vectored Influenza Vaccines Role of Egg-adaptation Mutations in Low Influenza A(H3N2) Vaccine Effectiveness During the 2012-2013 Season Flu's cues: Exploiting host post-translational modifications to direct the influenza virus replication cycle Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies Estimating Vaccine-Driven Selection in Seasonal Influenza

P2860

Q47227325-F6E90D5F-27ED-4CFA-9A15-D9D1B2B8ED3F Q47558185-F28CB732-1C78-4EF8-9064-97C3A049C0E9 Q49204982-07EDAC9C-F35A-4617-9270-FF77264167AB Q49981002-E46AD953-22E1-4059-AE7F-F0F2FD7AF945 Q51151777-BEF192D2-08D3-4391-9D8F-87EC6CCCB5B9 Q52565452-9F77C332-78E9-486B-B64F-3A209E6BC3BA Q52591749-4664A212-6889-4549-8071-FDD49B80835F Q52609655-FC39DE2B-F79F-4540-808A-FD7FF34AD1FC Q52627557-57E69EDD-4CA3-41D7-8A9C-A95F76BE1802 Q52671135-52800607-817D-4411-83CA-B6EDE37F24BC Q54234040-221D53B5-78BC-42C9-8C0A-E54D21693AD7 Q55513045-C7C0A9CB-F1B9-4CF4-A9AB-6EC9441B8C19 Q56535644-8405D4E0-E043-43C8-98AF-50B451E559FB Q56988172-4667FCC5-B57C-4E03-8C07-E83517384006 Q57094593-25D7EE2B-0CD7-4C0A-9494-D23EF79631CE Q57094631-4ED6EF80-6CAC-41FF-B9E3-78F8C10CB394 Q57462327-05291251-024A-4DD9-8211-500339F12DEF Q58712979-605D52AB-5EE7-4514-9E74-DA7B440B12E0 Q58721961-D4A88A24-20B6-4E80-8E3D-62B6DDC4CCD0 Q58722425-6B437D3F-0549-43EA-AC70-A6635AB02347

P2860

Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.

http://www.wikidata.org/entity/Q47150783

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Contemporary H3N2 influenza vi ...... y egg-adapted vaccine strains.

@en

Contemporary H3N2 influenza vi ...... y egg-adapted vaccine strains.

@nl

type

label

Contemporary H3N2 influenza vi ...... y egg-adapted vaccine strains.

@en

Contemporary H3N2 influenza vi ...... y egg-adapted vaccine strains.

@nl

prefLabel

Contemporary H3N2 influenza vi ...... y egg-adapted vaccine strains.

@en

Contemporary H3N2 influenza vi ...... y egg-adapted vaccine strains.

@nl

P1433

Q47150783-E801083B-5906-4EC4-8677-73342B3381C1

P1476

Q47150783-A5410733-5555-446D-82CC-E70B012FDBB5

P2093

Q47150783-19FB55F9-8285-4C74-AD80-2F0C7E3D93E4

Q47150783-3682D512-52C1-486C-82F1-3FF45B1AF222

Q47150783-476F0C8A-EFBB-4A36-BE6E-FEF741E89000

Q47150783-593B144E-A75D-4D47-82A9-698CDE517068

Q47150783-6324EB4F-5A77-4602-85C5-B2C7579EC112

Q47150783-BA2B12D9-AFBF-4F68-B3F3-FF2E4D840088

Q47150783-BFFF3FA1-BBAF-496F-B72A-4073D56D4B65

P2860

Q47150783-0287F03D-A8F5-4943-AA82-CA4DCFFF6053

Q47150783-060A4DDB-7338-4A24-9B43-46FE64E49BE2

Q47150783-187EBD27-A001-4AC3-9BC9-10678DAC28C5

Q47150783-19007656-31C5-402E-BAAD-7722C0C7EC3C

Q47150783-1FB3F919-2F71-476C-BDD5-C9222F574B1C

Q47150783-21AD1438-3C20-4ECE-A319-8349C18DD0ED

Q47150783-27DB29B5-6694-4A90-BC36-63319D2FB71E

Q47150783-2DC83497-B0C5-49C7-AC7A-E7AEECB6A02E

Q47150783-30602C2F-91C6-4DCF-9A4E-6183436766C0

Q47150783-30FE9664-3945-41FC-88C0-B5F1E2E91EC3

P304

Q47150783-3E5676A9-FBDB-417E-AF14-7BC1C4307A6B

P31

Q47150783-DFFF14F7-E3E9-47BE-ACA6-AA652CF1A520

P356

Q47150783-87F4EDE4-95D8-4FAF-89DB-0A8610472BE2

P407

Q47150783-AEF19FB0-42A4-4781-8177-74495D4F39DA

P433

Q47150783-D5DB59A3-B208-4972-AF7C-A29F15E42D1F

P478

Q47150783-42B4EB1F-4D88-4D56-A184-AE2BCF136F27

P50

Q47150783-B3A31216-0E75-4D81-B138-9F7BF3F35B97

Q47150783-E7ECFAA8-CFC9-4169-830E-1181D9D6C3B6

Q47150783-F1233179-DF28-4484-92A8-6D32ABDD827B

P577

Q47150783-08A60926-6C7A-4512-83BE-AE5301979D7C

P698

Q47150783-2D48B6CD-5ECF-450C-9BB5-FAA45D8F2B27

P921

Q47150783-5A2A055C-272E-4CBF-869F-A7CD7F728C37

Q47150783-EF42E3ED-FECD-4CE8-968E-0C56AE642B51

P932

Q47150783-F5064754-B14F-4C57-B2EA-06C6AA6E1B42

P356

PNAS.1712377114

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Contemporary H3N2 influenza vi ...... by egg-adapted vaccine strains

@en

P2093

Andrea J Sant

http://www.w3.org/2001/XMLSchema#string

John J Treanor

http://www.w3.org/2001/XMLSchema#string

Kaela Parkhouse

http://www.w3.org/2001/XMLSchema#string

Kangchon Kim

http://www.w3.org/2001/XMLSchema#string

Patrick C Wilson

http://www.w3.org/2001/XMLSchema#string

Sarah Cobey

http://www.w3.org/2001/XMLSchema#string

Sebastian Diaz Perez

http://www.w3.org/2001/XMLSchema#string

P2860

Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift

Mapping the antigenic and genetic evolution of influenza virus

Immune history shapes specificity of pandemic H1N1 influenza antibody responses.

Influenza vaccine: the challenge of antigenic drift.

Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin.

Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.

Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design.

Influenza vaccines: the good, the bad, and the eggs.

Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.

P304

12578-12583

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1712377114

http://www.w3.org/2001/XMLSchema#string

P407

P433

47

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P50

Scott E Hensley

P577

2017-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29109276

http://www.w3.org/2001/XMLSchema#string

P921

P932

5703309

http://www.w3.org/2001/XMLSchema#string